Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02575703 · ClinicalTrials.gov registry record · Phase 1
A Study of [¹⁴C]-LY3023414 in Healthy Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT02575703: Completed Phase 1 study, sponsored by Eli Lilly and Company.
NCT02575703 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02575703, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This type of study is called a radiolabeled study. For this study, LY3023414 has been specially prepared to contain the radioactive carbon atom \[¹⁴C\]. \[¹⁴C\] is a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study drug does not change how the drug works but helps to identify when the drug appears in the blood, urine, breath, and stool after it is given. The study will last about 15 days for each participant, not including screening. Screening is required within 28 days prior to enrollment. This study is for research purposes only and is not intended to treat any medical condition.
Interventions
- DRUG [¹⁴C]-LY3023414
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-10 |
| Est. Completion | 2015-11 |
| Phase | Phase 1 |
What the finished NCT02575703 record still lists
NCT02575703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which [¹⁴C]-LY3023414 is the first listed.
NCT02575703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02575703 about?
NCT02575703 is a clinical study titled "A Study of [¹⁴C]-LY3023414 in Healthy Participants". This type of study is called a radiolabeled study. For this study, LY3023414 has been specially prepared to contain the radioactive carbon atom \[¹⁴C\]. \[¹⁴C\] is a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study drug does not change how the d...
What is the current status of trial NCT02575703?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2015-10. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02575703?
The interventions under investigation include: [¹⁴C]-LY3023414 (DRUG).
Who is sponsoring clinical trial NCT02575703?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02575703's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia